Toradol v. Celecoxib for Postoperative Pain

• Status: Completed
• Trial end date: 2017-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

Randomized control trial between ketorolac versus celecoxib for postoperative pain following hysterectomy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tennessee Health Science Center
• Treatments: Celecoxib; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• Patients undergoing hysterectomy

Exclusion Criteria:

• Coronary Artery Disease

• Peptic Ulcer Disease

• Chronic Renal Disease

• Liver disease

• Alcohol Abuse

• Daily narcotic usage

• Narcotic use 24 hours prior to surgery

• Crohn's Disease

• History of myocardial infarction

• History of stroke

• Preoperative hematocrit less than 24

• Asthma

• Ulcerative Colitis

• Diverticulitis

• Aspirin Allergy

• Sulfonamide Allergy

• Pre-operative pain score of greater than 3

• Patients undergoing procedures that may involve bowel resection or bowel reanastomisis.

• Allergy to any non-steroidal anti-inflammatory drug

• Cardiac anomaly or disease

• Congestive Heart Failure